These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27004938)

  • 21. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction.
    Forte GI; Vaccarino L; Palmeri M; Branzi A; Caldarera CM; Scola L; Caruso C; Licastro F; Lio D
    Biogerontology; 2011 Oct; 12(5):485-90. PubMed ID: 21918818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia.
    Trifa AP; Cucuianu A; Popp RA; Coadă CA; Costache RM; Militaru MS; Vesa ŞC; Pop IV
    Ann Hematol; 2014 Feb; 93(2):203-9. PubMed ID: 23828072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombophilia and the risk for hemodialysis vascular access thrombosis.
    Knoll GA; Wells PS; Young D; Perkins SL; Pilkey RM; Clinch JJ; Rodger MA
    J Am Soc Nephrol; 2005 Apr; 16(4):1108-14. PubMed ID: 15728780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies.
    Sucker C; Kurschat C; Hetzel GR; Grabensee B; Maruhn-Debowski B; Loncar R; Ostojic L; Scharf RE; Zotz RB
    Clin Appl Thromb Hemost; 2009; 15(3):360-3. PubMed ID: 19448164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular behcet and mutations in thrombogenic genes: methylene tetrahydrofolate reductase, factor V, and prothrombin.
    Dagan E; Baruch Y; Fiorilli M; Rozenbaum M; Rosner I; Gershoni-Baruch R
    Genet Test Mol Biomarkers; 2012 Jan; 16(1):30-5. PubMed ID: 21861708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
    Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M; Salvarani C; Boiardi L; Accardo P; Iorio A; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Ciccia F; Ghirarduzzi A; Filippini D; Paolazzi G; Iori I
    Arthritis Rheum; 2004 Apr; 51(2):177-83. PubMed ID: 15077257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.
    Mazoyer E; Ripoll L; Gueguen R; Tiret L; Collet JP; dit Sollier CB; Roussi J; Drouet L;
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):503-10. PubMed ID: 19730248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia.
    Spina L; Saibeni S; Battaglioli T; Peyvandi F; de Franchis R; Vecchi M
    Am J Gastroenterol; 2005 Sep; 100(9):2036-41. PubMed ID: 16128949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
    Dindagur N; Kruthika-Vinod TP; Christopher R
    Thromb Res; 2007; 119(4):497-500. PubMed ID: 16781765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignancies, prothrombotic mutations, and the risk of venous thrombosis.
    Blom JW; Doggen CJ; Osanto S; Rosendaal FR
    JAMA; 2005 Feb; 293(6):715-22. PubMed ID: 15701913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and acquired prothrombotic risk factors and sudden hearing loss.
    Capaccio P; Ottaviani F; Cuccarini V; Bottero A; Schindler A; Cesana BM; Censuales S; Pignataro L
    Laryngoscope; 2007 Mar; 117(3):547-51. PubMed ID: 17334320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.